Abiopharma

Health In Tech Added to Membership of Russell Microcap® Index

Korn Ferry Announces Definitive Agreement to Acquire AMS

THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT

Matador Resources Company Announces Expansion of San Mateo’s Delaware Basin Footprint Through the Acquisition of Cardinal Midstream

Constellium Sells Automotive Structures Joint Venture in Changchun, China

Comcast Announces Plans to Separate Media and Technology Businesses Into Two Leading Public Companies

Zymeworks to Acquire Theravance Biopharma, Inc.

Global Net Lease Closes $74 Million of Dispositions Since First Quarter 2026, Achieving a 7.2% Cash Cap Rate on Occupied Sales

Designated Market Maker (DMM) Obligations: United States Public Holiday on 3 July 2026

Warrants Listing - Structured Warrants: Launch Announcement